Was The Smart Money Right About Mesa Laboratories, Inc. (MLAB)?
Hedge funds don't get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds.
Mesa Laboratories Inc (MLAB)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Is Mesa Laboratories, Inc. (MLAB) A Good Stock To Buy ?
The market has been volatile in the last few months as the Federal Reserve finalized its rate cuts and uncertainty looms over trade negotiations with China.
Hedge Funds Are Dumping Mesa Laboratories, Inc. (MLAB)
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Hedge Funds Have Never Been More Bullish On Mesa Laboratories, Inc. (MLAB)
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of March.
Is Mesa Laboratories, Inc. (MLAB) A Good Stock To Buy?
"Value has performed relatively poorly since the 2017 shift, but we believe challenges to the S&P 500’s dominance are mounting and resulting active opportunities away from the index are growing.
Hedge Fund and Insider Trading News: Carl Icahn, Eddie Lampert, John D. Arnold, Tiger Global Management, Intrepid Potash, Inc. (IPI), Cytocore (MDIT), and More
Activist investor Carl Icahn scored a big payday on Monday after shares of tanker car maker American Railcar Industries surged on news that the company will merge with a subsidiary of ITE Rail Fund.
13G Filing: Nine Ten Partners and Mesa Laboratories Inc (MLAB)
You can access the original SEC filing by clicking here.
Insider Buying at 3 Companies Amid Historically Low Insider Buying, Plus Insider Selling at 2 Companies
According to research firm TrimTabs, the dollar volume of insider buying from early-October through the end of last week stood at about $110 million, representing the lowest monthly total in the past ...
Hedge Funds Are Buying Harvard Bioscience, Inc. (HBIO)
Harvard Bioscience, Inc. (NASDAQ:HBIO) was in 8 hedge funds' portfolio at the end of March.
This Metric Says You Are Smart to Sell STAAR Surgical Company (STAA)
STAAR Surgical Company (NASDAQ:STAA) was in 7 hedge funds' portfolio at the end of March. STAA shareholders have witnessed a decrease in enthusiasm from smart money in recent months.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
